How is patient safety ensured in clinical trials?

Participant safety is the top priority in any clinical trial. Although often perceived as new or unfamiliar, clinical trials are among the most tightly regulated processes in medicine. Every stage, from planning to conduct, is subject to clear rules that aim to protect the health and rights of patients.

What are clinical trials

Clinical trials are scientific studies that evaluate the effectiveness and safety of new drugs, therapies or medical methods. They are a necessary step before a treatment becomes widely available.

Strict selection of patients

One of the first mechanisms to ensure safety is the precise selection of participants.

Each patient must meet specific inclusion criteria, which may include:

• age
• diagnosis and stage of the disease
• laboratory indicators
• general health

There are also exclusion criteria that prevent participation of patients who may be at increased risk.

Informed consent

Prior to enrollment in a clinical trial, each patient goes through an informed consent process.

This means that the patient:

• receives detailed information about the study
• understands the potential benefits and risks
• has the opportunity to ask questions
• signs a consent only if they wish to participate

It is important to know that participation is completely voluntary and can be terminated at any time.

Permanent medical control

During the clinical trial, patients are under regular medical supervision, which is often more detailed than standard medical practice.

This includes:

• regular check-ups
• laboratory tests
• condition tracking
• timely response to changes

This constant monitoring ensures early detection of any adverse reactions.

Role of ethics committees

Each clinical study is approved by an independent ethics committee, which evaluates:

• protocol safety
• the benefit-risk ratio
• the protection of patients' rights

Without ethics committee approval, the study cannot begin. In Bulgaria, this process is central and is carried out by the Ethics Committee for Clinical Trials (ECCT).

International Quality Standards (GCP)

Clinical trials are conducted according to the standards of Good Clinical Practice (GCP).

These standards ensure:

• protection of participants
• data reliability
• transparency of processes

GCP is applied globally and is mandatory for all clinical trials.

Monitoring and control by sponsors and regulators

In addition to the medical team, the clinical trials are overseen by:

• the study sponsor
• clinical monitors (CRA)
• national and international regulatory authorities - the IMA and the European Medicines Agency (EMA)

This provides an additional layer of control and ensures compliance with all requirements.

What it means for the patient

For patients, participation in a clinical trial means:

• access to new therapies
• follow-up by a specialized medical team
• clear and transparent information
• the possibility of cancellation at any time

All of these factors make clinical trials a safe and controlled environment.

Conclusion

Patient safety in clinical trials is ensured through a combination of rigorous recruitment, informed consent, ongoing medical monitoring and international standards. This makes clinical trials a reliable and important tool for the development of modern medicine.